Alternative Dosing Regimens for Atezolizumab: An Example of Model-Informed Drug Development in the Postmarketing Setting

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-019-03954-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Model Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2020English

Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development

Clinical Pharmacology and Therapeutics
Pharmacology
2020English

The Implications of Model-Informed Drug Discovery and Development for Tuberculosis

Drug Discovery Today
Drug DiscoveryPharmacology
2017English

Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling

Journal of Clinical Pharmacology
Pharmacology
2019English

Optimization of Dosing Regimens and Dosing in Special Populations

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Drug Repurposing as an Efficient Strategy in Drug Development – Example of CNS Area

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Air Pouch Model: An Alternative Method for Cancer Drug Discovery

2019English

Ribozyme Pharmacokinetic Screening for Predicting Pharmacodynamic Dosing Regimens

Current Issues in Molecular Biology
MedicineMicrobiologyMolecular Biology
2000English

Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy